, Tracking Stock Market Picks
Enter Symbol:
Omeros Corporation (OMER) [hlAlert]

up 1.41 %

Omeros Corporation (OMER) rated Buy with price target $38 by ROTH Capital

Posted on: Monday,  Aug 10, 2015  8:25 AM ET by Roth Capital

Roth Capital rated Buy Omeros Corporation (NASDAQ: OMER) on 08/10/2015, when the stock price was $15.54. Since
then, Omeros Corporation has gained 1.42% as of 01/26/2016's recent price of $15.76.
If you would have followed this Roth Capital's recommendation on OMER, you would have gained 1.41% of your investment in 169 days.

Omeros Corporation is a clinical-stage biopharmaceutical company engaged in discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. The Company?s clinically advanced product candidates are derived from its PharmacoSurgerytm platform designed to improve the clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Its PharmacoSurgery platform is based on low-dose combinations of therapeutic agents delivered directly to the surgical site throughout the duration of the procedure to preemptively inhibit inflammation and other problems caused by surgical trauma and to provide clinical benefits both during and after surgery.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/10/2015 8:25 AM Buy
15.54 38.00
as of 8/27/2015
1 Week up  5.84 %
1 Month up  1.41 %
3 Months   
1 YTD up  1.41 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy